X4 Pharmaceuticals (XFOR) Profit After Tax (2018 - 2025)
Historic Profit After Tax for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to -$29.8 million.
- X4 Pharmaceuticals' Profit After Tax rose 1875.14% to -$29.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$95.1 million, marking a year-over-year decrease of 46731.91%. This contributed to the annual value of -$37.4 million for FY2024, which is 6298.2% up from last year.
- According to the latest figures from Q3 2025, X4 Pharmaceuticals' Profit After Tax is -$29.8 million, which was up 1875.14% from -$25.7 million recorded in Q2 2025.
- X4 Pharmaceuticals' Profit After Tax's 5-year high stood at $90.8 million during Q2 2024, with a 5-year trough of -$55.7 million in Q2 2023.
- Moreover, its 5-year median value for Profit After Tax was -$22.0 million (2022), whereas its average is -$19.8 million.
- Over the last 5 years, X4 Pharmaceuticals' Profit After Tax had its largest YoY gain of 26304.03% in 2024, and its largest YoY loss of 149201.74% in 2024.
- X4 Pharmaceuticals' Profit After Tax (Quarter) stood at -$30.2 million in 2021, then rose by 3.65% to -$29.1 million in 2022, then surged by 34.27% to -$19.1 million in 2023, then crashed by 108.16% to -$39.8 million in 2024, then increased by 25.13% to -$29.8 million in 2025.
- Its Profit After Tax stands at -$29.8 million for Q3 2025, versus -$25.7 million for Q2 2025 and $300000.0 for Q1 2025.